QRX

QRXPHARMA LTD - Announcements

0.00%

2.8¢

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

QRX	Moxduo Post Advisory Committee Meeting Investor Call Details		17/04/14	306.4KB	Share
QRX	Trading Halt	PRICE SENSITIVE	17/04/14	1.16MB	Share
QRX	FDA sets 22 April 2014 for Moxduo Advisory Committee Meeting		24/03/14	279.99KB	Share
QRX	Appendix 3B - Exercise of Stock Options		10/03/14	345.7KB	Share
QRX	ASX / Media Release - Results Half Year 31 December 2013		25/02/14	278.91KB	Share
QRX	Half Yearly Report and Accounts - 31 December 2013	PRICE SENSITIVE	25/02/14	653.46KB	Share
QRX	Appendix 3B - Exercise of Stock Options		30/01/14	347.38KB	Share
QRX	Appendix 4C - Quarter Ended 31 December 2013	PRICE SENSITIVE	29/01/14	552.74KB	Share
QRX	Details of Company Address		22/01/14	178.26KB	Share
QRX	Holaday - Cease to be substantial holder		17/12/13	16.73KB	Share
QRX	Change of Director's Interest Notice - Peter Campbell		17/12/13	223.65KB	Share
QRX	QRxPharma Despatches SPP Holding Statements		16/12/13	274.15KB	Share
QRX	Appendix 3B - Share Purchase Plan		13/12/13	347.73KB	Share
QRX	$4.1 Million SPP Completes A$11.6 Million Capital Raising	PRICE SENSITIVE	13/12/13	328.79KB	Share
QRX	25 May 2014 as New PDUFA Date for MOXDUO NDA		11/12/13	325.23KB	Share
QRX	MOXDUO License with TEVA for Commercialisation in Israel	PRICE SENSITIVE	27/11/13	417.03KB	Share
QRX	QRxPharma Refiles MOXDUO New Drug Application with the FDA	PRICE SENSITIVE	26/11/13	326.1KB	Share
QRX	Change in substantial holding		19/11/13	89.53KB	Share
QRX	Appendix 3B - Option Issue		19/11/13	415.17KB	Share
QRX	Notification Section 708A(5)(e) Corporations Act 2001 (Cth)		18/11/13	286.03KB	Share
QRX	Appendix 3B - Placement Issue announced 13 November 2013		18/11/13	344.84KB	Share
QRX	Share Purchase Plan Opens 19 November 2013		15/11/13	911.75KB	Share
QRX	Placement and SPP - ASX Listing Rule 3.10.3 Notice		13/11/13	276.3KB	Share
QRX	Results of 2013 Annual General Meeting		13/11/13	60.37KB	Share
QRX	Chairman and Managing Director Addresses to Shareholders		13/11/13	405.86KB	Share
QRX	Successful Completion of A$7.5 Million Placement	PRICE SENSITIVE	13/11/13	329.1KB	Share
QRX	Investor Update and Capital Raising - November 2013		11/11/13	1.3MB	Share
QRX	Trading Halt	PRICE SENSITIVE	11/11/13	267.9KB	Share
QRX	Appendix 4C - Quarter Ended 30 September 2013	PRICE SENSITIVE	28/10/13	600.26KB	Share
QRX	QRxPharma Extends MOXDUO License with Aspen	PRICE SENSITIVE	15/10/13	324.79KB	Share
QRX	Notice of 2013 Annual General Meeting and Proxy Form		10/10/13	680.54KB	Share
QRX	QRxPharma reports Positive Meeting with the FDA on MOXDUO	PRICE SENSITIVE	09/10/13	325.34KB	Share
QRX	Annual Report to Shareholders - 2013		25/09/13	1.92MB	Share
QRX	2013 Annual General Meeting - Wednesday, 13 November 2013		17/09/13	273.78KB	Share
QRX	QRxPharma Announces MOXDUO License with Aspen	PRICE SENSITIVE	11/09/13	327.1KB	Share
QRX	FDA Schedules Review Meeting Regarding MOXDUO NDA		06/09/13	325.03KB	Share
QRX	ASX/ Media Release - Preliminary Final Report 30 June 2013		29/08/13	329.49KB	Share
QRX	Preliminary Final Report - 30 June 2013	PRICE SENSITIVE	29/08/13	1.43MB	Share
QRX	CEO discusses Complete Response Letter on Open Briefing		28/08/13	414.13KB	Share
QRX	Complete Response Letter from FDA regarding MOXDUO NDA	PRICE SENSITIVE	28/08/13	423.77KB	Share
QRX	Trading Halt	PRICE SENSITIVE	26/08/13	128.71KB	Share
QRX	Appendix 4C - Quarter Ended 30 June 2013	PRICE SENSITIVE	26/07/13	603.57KB	Share
QRX	QRxPharma Announces Collaboration with Aesica	PRICE SENSITIVE	22/07/13	341.76KB	Share
QRX	Change in substantial holding		09/07/13	87.14KB	Share
QRX	CEO discusses MOXDUO NDA Review Update on Open Briefing		27/06/13	399.37KB	Share
QRX	QRxPharma Updates MOXDUO NDA Review	PRICE SENSITIVE	26/06/13	333.63KB	Share
QRX	Trading Halt	PRICE SENSITIVE	26/06/13	183.41KB	Share
QRX	Appendix 3B - Exercise of Stock Options		14/06/13	343.11KB	Share
QRX	QRxPharma Granted US Patent on Hybrid Opioids	PRICE SENSITIVE	12/06/13	324.87KB	Share
QRX	Appendix 3B - Exercise of Stock Options		05/06/13	343.36KB	Share
QRX	FDA sets 17 July 2013 for MOXDUO Advisory Committee Meeting	PRICE SENSITIVE	17/05/13	327.64KB	Share
QRX	Appendix 3B - Exercise of Stock Options		09/05/13	343.32KB	Share
QRX	Appendix 4C - Quarter Ended 31 March 2013	PRICE SENSITIVE	29/04/13	597.82KB	Share
QRX	FDA sets 26 August 2013 as new PDUFA date for MOXDUO NDA		14/03/13	325.85KB	Share
QRX	Investor Presentation Update - March 2013		01/03/13	1.99MB	Share
QRX	QRxPharma Resubmits MOXDUO New Drug Application to the FDA	PRICE SENSITIVE	28/02/13	327.05KB	Share
QRX	Appendix 3B - Option Issue		21/02/13	327.78KB	Share
QRX	Investor Presentation Update - February 2013		18/02/13	1.43MB	Share
QRX	Half Yearly Report and Accounts - 31 December 2012	PRICE SENSITIVE	18/02/13	672.41KB	Share
QRX	Appendix 4C - Quarter Ended 31 December 2012	PRICE SENSITIVE	24/01/13	602.09KB	Share
QRX	CEO discusses Path Forward for Resubmission of MOXDUO NDA		17/01/13	398.43KB	Share
QRX	Path Forward For Resubmission of MOXDUO NDA	PRICE SENSITIVE	16/01/13	330.73KB	Share
QRX	Appendix 3B - Exercise of Stock Options		14/01/13	327.15KB	Share
QRX	Appendix 3B - Exercise of Stock Options		20/12/12	327.22KB	Share
QRX	Investor Presentation Update - December 2012		11/12/12	2.05MB	Share
QRX	Change in substantial holding		06/12/12	89.22KB	Share
QRX	MAP Cancellation		06/12/12	9.07KB	Share
QRX	Change in substantial holding		06/12/12	179.79KB	Share
QRX	Ceasing to be a substantial holder		28/11/12	50.05KB	Share
QRX	Change of Director's Interest Notice - Michael Quinn		22/11/12	292.11KB	Share
QRX	Change of Director's Interest Notice - Gary Pace		22/11/12	223.93KB	Share
QRX	Change of Director's Interest Notice - Peter Farrell		22/11/12	224.03KB	Share
QRX	Change of Director's Interest Notice - Michael Quinn		21/11/12	293.79KB	Share
QRX	Change of Director's Interest Notice - John Holaday		12/11/12	225.41KB	Share
QRX	Appendix 3B - Option Issue		12/11/12	393.18KB	Share
QRX	Change of Director's Interest Notice - Peter Campbell		12/11/12	224.18KB	Share
QRX	Change of Director's Interest Notice - Peter Farrell		12/11/12	217.1KB	Share
QRX	Change of Director's Interest Notice - Michael Quinn		12/11/12	224.11KB	Share
QRX	Change of Director's Interest Notice - Gary Pace		12/11/12	223.85KB	Share
QRX	Results of 2012 Annual General Meeting		07/11/12	59.45KB	Share
QRX	Chairman and Managing Director Addresses to Shareholders		07/11/12	413.69KB	Share
QRX	Appendix 4C - Quarter Ended 30 September 2012	PRICE SENSITIVE	26/10/12	600.53KB	Share
QRX	Strategic Collaboration with Paladin Labs	PRICE SENSITIVE	10/10/12	382.21KB	Share
QRX	Notice of 2012 Annual General Meeting and Proxy Form		05/10/12	849.09KB	Share
QRX	Change in substantial holding		24/09/12	90KB	Share
QRX	Annual Report to Shareholders - 2012		21/09/12	5.78MB	Share
QRX	2012 Annual General Meeting - Wednesday, 7 November 2012		13/09/12	303.67KB	Share
QRX	Investor Presentation Update - September 2012		06/09/12	1.12MB	Share
QRX	Independent Audit Report - 30 June 2012		03/09/12	303.07KB	Share
QRX	ASX/ Media Release - Preliminary Final Report 30 June 2012		30/08/12	380.5KB	Share
QRX	Preliminary Final Report - 30 June 2012	PRICE SENSITIVE	30/08/12	1002.3KB	Share
QRX	CEO discusses Productive Meeting with FDA regarding MOXDUO		21/08/12	374.75KB	Share
QRX	Productive Meeting With FDA Regarding MOXDUO NDA	PRICE SENSITIVE	20/08/12	381.12KB	Share
QRX	Appendix 4C - Quarter Ended 30 June 2012	PRICE SENSITIVE	24/07/12	651.35KB	Share
QRX	Change in substantial holding		11/07/12	485.22KB	Share
PDL +QRX	Ceasing to be a substantial holder from BTT		29/06/12	75.74KB	Share
QRX +WBC	Ceasing to be a substantial holder from WBC		29/06/12	226.58KB	Share
QRX	CEO discusses Complete Response Letter from FDA		27/06/12	375.03KB	Share
QRX	Complete Response Letter from FDA regarding MOXDUO NDA	PRICE SENSITIVE	27/06/12	380.04KB	Share
QRX	Trading Halt	PRICE SENSITIVE	25/06/12	280.29KB	Share

QRXMoxduo Post Advisory Committee Meeting Investor Call Details
17/04/14		306.4KB	Share
QRXTrading Halt
17/04/14	PRICE SENSITIVE	1.16MB	Share
QRXFDA sets 22 April 2014 for Moxduo Advisory Committee Meeting
24/03/14		279.99KB	Share
QRXAppendix 3B - Exercise of Stock Options
10/03/14		345.7KB	Share
QRXASX / Media Release - Results Half Year 31 December 2013
25/02/14		278.91KB	Share
QRXHalf Yearly Report and Accounts - 31 December 2013
25/02/14	PRICE SENSITIVE	653.46KB	Share
QRXAppendix 3B - Exercise of Stock Options
30/01/14		347.38KB	Share
QRXAppendix 4C - Quarter Ended 31 December 2013
29/01/14	PRICE SENSITIVE	552.74KB	Share
QRXDetails of Company Address
22/01/14		178.26KB	Share
QRXHoladay - Cease to be substantial holder
17/12/13		16.73KB	Share
QRXChange of Director's Interest Notice - Peter Campbell
17/12/13		223.65KB	Share
QRXQRxPharma Despatches SPP Holding Statements
16/12/13		274.15KB	Share
QRXAppendix 3B - Share Purchase Plan
13/12/13		347.73KB	Share
QRX$4.1 Million SPP Completes A$11.6 Million Capital Raising
13/12/13	PRICE SENSITIVE	328.79KB	Share
QRX25 May 2014 as New PDUFA Date for MOXDUO NDA
11/12/13		325.23KB	Share
QRXMOXDUO License with TEVA for Commercialisation in Israel
27/11/13	PRICE SENSITIVE	417.03KB	Share
QRXQRxPharma Refiles MOXDUO New Drug Application with the FDA
26/11/13	PRICE SENSITIVE	326.1KB	Share
QRXChange in substantial holding
19/11/13		89.53KB	Share
QRXAppendix 3B - Option Issue
19/11/13		415.17KB	Share
QRXNotification Section 708A(5)(e) Corporations Act 2001 (Cth)
18/11/13		286.03KB	Share
QRXAppendix 3B - Placement Issue announced 13 November 2013
18/11/13		344.84KB	Share
QRXShare Purchase Plan Opens 19 November 2013
15/11/13		911.75KB	Share
QRXPlacement and SPP - ASX Listing Rule 3.10.3 Notice
13/11/13		276.3KB	Share
QRXResults of 2013 Annual General Meeting
13/11/13		60.37KB	Share
QRXChairman and Managing Director Addresses to Shareholders
13/11/13		405.86KB	Share
QRXSuccessful Completion of A$7.5 Million Placement
13/11/13	PRICE SENSITIVE	329.1KB	Share
QRXInvestor Update and Capital Raising - November 2013
11/11/13		1.3MB	Share
QRXTrading Halt
11/11/13	PRICE SENSITIVE	267.9KB	Share
QRXAppendix 4C - Quarter Ended 30 September 2013
28/10/13	PRICE SENSITIVE	600.26KB	Share
QRXQRxPharma Extends MOXDUO License with Aspen
15/10/13	PRICE SENSITIVE	324.79KB	Share
QRXNotice of 2013 Annual General Meeting and Proxy Form
10/10/13		680.54KB	Share
QRXQRxPharma reports Positive Meeting with the FDA on MOXDUO
09/10/13	PRICE SENSITIVE	325.34KB	Share
QRXAnnual Report to Shareholders - 2013
25/09/13		1.92MB	Share
QRX2013 Annual General Meeting - Wednesday, 13 November 2013
17/09/13		273.78KB	Share
QRXQRxPharma Announces MOXDUO License with Aspen
11/09/13	PRICE SENSITIVE	327.1KB	Share
QRXFDA Schedules Review Meeting Regarding MOXDUO NDA
06/09/13		325.03KB	Share
QRXASX/ Media Release - Preliminary Final Report 30 June 2013
29/08/13		329.49KB	Share
QRXPreliminary Final Report - 30 June 2013
29/08/13	PRICE SENSITIVE	1.43MB	Share
QRXCEO discusses Complete Response Letter on Open Briefing
28/08/13		414.13KB	Share
QRXComplete Response Letter from FDA regarding MOXDUO NDA
28/08/13	PRICE SENSITIVE	423.77KB	Share
QRXTrading Halt
26/08/13	PRICE SENSITIVE	128.71KB	Share
QRXAppendix 4C - Quarter Ended 30 June 2013
26/07/13	PRICE SENSITIVE	603.57KB	Share
QRXQRxPharma Announces Collaboration with Aesica
22/07/13	PRICE SENSITIVE	341.76KB	Share
QRXChange in substantial holding
09/07/13		87.14KB	Share
QRXCEO discusses MOXDUO NDA Review Update on Open Briefing
27/06/13		399.37KB	Share
QRXQRxPharma Updates MOXDUO NDA Review
26/06/13	PRICE SENSITIVE	333.63KB	Share
QRXTrading Halt
26/06/13	PRICE SENSITIVE	183.41KB	Share
QRXAppendix 3B - Exercise of Stock Options
14/06/13		343.11KB	Share
QRXQRxPharma Granted US Patent on Hybrid Opioids
12/06/13	PRICE SENSITIVE	324.87KB	Share
QRXAppendix 3B - Exercise of Stock Options
05/06/13		343.36KB	Share
QRXFDA sets 17 July 2013 for MOXDUO Advisory Committee Meeting
17/05/13	PRICE SENSITIVE	327.64KB	Share
QRXAppendix 3B - Exercise of Stock Options
09/05/13		343.32KB	Share
QRXAppendix 4C - Quarter Ended 31 March 2013
29/04/13	PRICE SENSITIVE	597.82KB	Share
QRXFDA sets 26 August 2013 as new PDUFA date for MOXDUO NDA
14/03/13		325.85KB	Share
QRXInvestor Presentation Update - March 2013
01/03/13		1.99MB	Share
QRXQRxPharma Resubmits MOXDUO New Drug Application to the FDA
28/02/13	PRICE SENSITIVE	327.05KB	Share
QRXAppendix 3B - Option Issue
21/02/13		327.78KB	Share
QRXInvestor Presentation Update - February 2013
18/02/13		1.43MB	Share
QRXHalf Yearly Report and Accounts - 31 December 2012
18/02/13	PRICE SENSITIVE	672.41KB	Share
QRXAppendix 4C - Quarter Ended 31 December 2012
24/01/13	PRICE SENSITIVE	602.09KB	Share
QRXCEO discusses Path Forward for Resubmission of MOXDUO NDA
17/01/13		398.43KB	Share
QRXPath Forward For Resubmission of MOXDUO NDA
16/01/13	PRICE SENSITIVE	330.73KB	Share
QRXAppendix 3B - Exercise of Stock Options
14/01/13		327.15KB	Share
QRXAppendix 3B - Exercise of Stock Options
20/12/12		327.22KB	Share
QRXInvestor Presentation Update - December 2012
11/12/12		2.05MB	Share
QRXChange in substantial holding
06/12/12		89.22KB	Share
QRXMAP Cancellation
06/12/12		9.07KB	Share
QRXChange in substantial holding
06/12/12		179.79KB	Share
QRXCeasing to be a substantial holder
28/11/12		50.05KB	Share
QRXChange of Director's Interest Notice - Michael Quinn
22/11/12		292.11KB	Share
QRXChange of Director's Interest Notice - Gary Pace
22/11/12		223.93KB	Share
QRXChange of Director's Interest Notice - Peter Farrell
22/11/12		224.03KB	Share
QRXChange of Director's Interest Notice - Michael Quinn
21/11/12		293.79KB	Share
QRXChange of Director's Interest Notice - John Holaday
12/11/12		225.41KB	Share
QRXAppendix 3B - Option Issue
12/11/12		393.18KB	Share
QRXChange of Director's Interest Notice - Peter Campbell
12/11/12		224.18KB	Share
QRXChange of Director's Interest Notice - Peter Farrell
12/11/12		217.1KB	Share
QRXChange of Director's Interest Notice - Michael Quinn
12/11/12		224.11KB	Share
QRXChange of Director's Interest Notice - Gary Pace
12/11/12		223.85KB	Share
QRXResults of 2012 Annual General Meeting
07/11/12		59.45KB	Share
QRXChairman and Managing Director Addresses to Shareholders
07/11/12		413.69KB	Share
QRXAppendix 4C - Quarter Ended 30 September 2012
26/10/12	PRICE SENSITIVE	600.53KB	Share
QRXStrategic Collaboration with Paladin Labs
10/10/12	PRICE SENSITIVE	382.21KB	Share
QRXNotice of 2012 Annual General Meeting and Proxy Form
05/10/12		849.09KB	Share
QRXChange in substantial holding
24/09/12		90KB	Share
QRXAnnual Report to Shareholders - 2012
21/09/12		5.78MB	Share
QRX2012 Annual General Meeting - Wednesday, 7 November 2012
13/09/12		303.67KB	Share
QRXInvestor Presentation Update - September 2012
06/09/12		1.12MB	Share
QRXIndependent Audit Report - 30 June 2012
03/09/12		303.07KB	Share
QRXASX/ Media Release - Preliminary Final Report 30 June 2012
30/08/12		380.5KB	Share
QRXPreliminary Final Report - 30 June 2012
30/08/12	PRICE SENSITIVE	1002.3KB	Share
QRXCEO discusses Productive Meeting with FDA regarding MOXDUO
21/08/12		374.75KB	Share
QRXProductive Meeting With FDA Regarding MOXDUO NDA
20/08/12	PRICE SENSITIVE	381.12KB	Share
QRXAppendix 4C - Quarter Ended 30 June 2012
24/07/12	PRICE SENSITIVE	651.35KB	Share
QRXChange in substantial holding
11/07/12		485.22KB	Share
PDL +QRXCeasing to be a substantial holder from BTT
29/06/12		75.74KB	Share
QRX +WBCCeasing to be a substantial holder from WBC
29/06/12		226.58KB	Share
QRXCEO discusses Complete Response Letter from FDA
27/06/12		375.03KB	Share
QRXComplete Response Letter from FDA regarding MOXDUO NDA
27/06/12	PRICE SENSITIVE	380.04KB	Share
QRXTrading Halt
25/06/12	PRICE SENSITIVE	280.29KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

QRXPHARMA LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available